Baxter and haemophilia
About Baxter
Baxter is a global medical products and services company which has played a leading role in healthcare provision for over 70 years.
In the UK, Baxter supplies thousands of medical products and services to almost every hospital, as well as working on supporting more and more patients in the community. Over 1250 people are employed in the UK to combine a virtually unparalleled ability to meet the demand of today and tomorrow's health care needs.
At Baxter, we focus on assisting people with some of the most complex conditions — for example, haemophilia, cancer, immune disorders and kidney disease. We do this by applying our expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.
Baxter's place in haemophilia care
Over the years, Baxter has forged a reputation for showing unwavering commitment to the haemophilia community, producing a portfolio of therapeutic proteins that prevent and treat bleeding episodes. Our latest recombinant clotting factors are produced without the addition of materials of human or animal origin at any stage of the manufacturing process or in the finished product. We work closely with doctors and nurses to serve and support them and to become their partner in providing the best possible care for people with haemophilia.
